Emerging therapies in multiple myeloma
The treatment of multiple myeloma has evolved significantly over the past 2 decades due to the use of high-dose chemotherapy and autologous stem cell transplantation, and the subsequent introduction of the immunomodulatory agents (thalidomide and lenalidomide) and the proteasome inhibitor (bortezomi...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | article |
| Published: |
2015
|
| Online Access: | http://hdl.handle.net/10725/6243 http://dx.doi.org/10.1097/COC.0b013e3182a4676b http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php http://journals.lww.com/amjclinicaloncology/Abstract/2015/06000/Emerging_Therapies_in_Multiple_Myeloma.15.aspx |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|